Executive Profile

Elaine V. Jones Ph.D. Executive Director, Venture Capital-Worldwide Business Development, Pfizer Venture Investments

Age	Total Calculated Compensation	This person is connected to 6 Board Members in 6 different organizations across 11 different industries. See Board Relationships
--	--

Background

Dr. Elaine V. Jones, Ph.D., serves as an Executive Director of Venture Capital-Worldwide Business Development at Pfizer Venture Investments. Dr. Jones served as Vice President of EuclidSR Partners L.P. She has 10 years of venture capital experience and a strong background in research and product assessment, built on her significant experience in pharmaceutical drug discovery and business development. Dr. Jones served as a Director of Scientific Licensing at SmithKline ... Beecham Pharmaceuticals since 1994. She was a Research Scientist in SmithKline Beecham Pharmaceutical R&D. She served as Vice President of SR One from September 2001 to August 2003 and its Investment Manager from June 1999 to September 2001, where she managed investments including Adolor, Avantium, Nucleonics, Scynexis, and Vicuron. She served as a General Partner of EuclidSR Partners. She has been a Board Observer of Neuronetics, Inc. since May 16, 2011 and Merus Biopharmaceuticals B.V. since January 2010. She serves as a Director at Aquinox Pharmaceuticals, Inc. Dr. Jones has been a Director of NeuroTherapeutics Pharma, Inc. since May 2010. She serves as a Director of Mirna Therapeutics, Inc, Horsham, PA, Flexion Therapeutics, Inc., South San Francisco, CA, and Nucleonics, Inc. She serves as a Director and Member of Life Sciences Investment Advisory Committee at Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm. She served as a Director of InnaPhase Corporation and Acurian, Inc. She served as a Director of Avantium Technologies B.V. She served as a Director of Targacept, Inc. from August 2000 to June 13, 2007 and Fluidigm Corporation since October 2001. Dr. Jones is a graduate of Juniata College and received a Ph.D. in Microbiology from the University of Pittsburgh.

Corporate Headquarters 235 East 42nd Street New York, New York 10017-5755 United States Phone: 212-733-2323 Fax: 212-573-7851 Board Members Memberships Member of Life Sciences Investment Advisory Committee Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm Former Director InnaPhase Corporation Former Director Acurian, Inc. Former Director Avantium Technologies B.V. Director Nucleonics, Inc. Director Aquinox Pharmaceuticals, Inc. Director Mirna Therapeutics, Inc. Member of The Board of Directors Flexion Therapeutics, Inc. 2000-2007 Former Director and Member of Compensation Committee Targacept, Inc. 2001-N/A Former Director, Chairman of Nominating & Governance Committee and Member of Audit Committee Fluidigm Corporation 2010-Present Director NeuroTherapeutics Pharma, Inc. Education PhD University of Pittsburgh Unknown/Other Education Juniata College Other Affiliations Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm EuclidSR Partners SR One InnaPhase Corporation Acurian, Inc. Targacept, Inc. Avantium Technologies B.V. Fluidigm Corporation Neuronetics, Inc. EuclidSR Partners, L.P. University of Pittsburgh Juniata College Nucleonics, Inc. Merus Biopharmaceuticals B.V. Aquinox Pharmaceuticals, Inc. NeuroTherapeutics Pharma, Inc. Mirna Therapeutics, Inc. Flexion Therapeutics, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.